[1]
Wolszczak, A. et al. 2026. SARCOPENIC OBESITY IN THE ERA OF INCRETIN-BASED THERAPIES: DIAGNOSTIC CHALLENGES, THE RISK OF MUSCLE MASS LOSS, AND PREVENTION STRATEGIES. International Journal of Innovative Technologies in Social Science. 1, 3(51) (Aug. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.5940.